Clinical trial
Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in…
NCT00478322 · Incyte Corporation, Industry · Completed
Key facts
| NCT number | NCT00478322 |
|---|---|
| Title | Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects |
| Lead sponsor | Incyte Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Obesity |
| Intervention type | Drug |
| Interventions | Placebo, INCB013739 |
| Enrollment | 24 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | May 24, 2007 |
| Last update posted | Dec 6, 2016 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: